Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
3.200
-0.120 (-3.61%)
At close: Jun 27, 2025, 4:00 PM
3.368
+0.168 (5.26%)
After-hours: Jun 27, 2025, 6:18 PM EDT
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
187.50M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
OMER News
- 1 day ago - Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA - Business Wire
- 4 days ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - Business Wire
- 18 days ago - Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga
- 4 weeks ago - Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster - Seeking Alpha
- 4 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 6 weeks ago - Omeros Corporation (OMER) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Omeros Corporation Reports First Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025 - Business Wire